Aurora Cannabis opened lower at $5.00, compared with its previous close of $5.05. In the last trading session, the stock traded between $4.98 and $5.10. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Aurora Cannabis is now worth
$ 6.60
Resulting in a loss of
$ 93.40 (93.40%)
Note: Past profits do not guarantee future returns.
Rating from 3 Analysts
Today's Change
$-0.06 (-1.09%)
Day High
$5.10
Day Low
$4.98
Day Open
$5.00
Prev Close
$5.05
Volume
19,30,382
1W Return
-4.44%
1M Return
14.62%
3M Return
43.33%
6M Return
46.05%
1Y Return
9.78%
Market Cap ($ Mn)
328
PE Ratio
-
PB Ratio
0.68
PEG Ratio
-
ROE
2.81%
ROCE
2.41%
EPS (TTM)
$-0.33
1 Week
-4.44%
1 Month
14.62%
3 Months
43.33%
6 Months
46.05%
9 Months
45.20%
Aurora Cannabis shares rise on C$561 million Organigram takeover deal
Organigram Global agreed to acquire Aurora Cannabis Inc for C$7.80 per share, valuing the equity at approximately C$561 million. Aurora shares rose 19.67% to $5.05 as the deal tops Curaleaf's hostile bid by 21%. Shareholders may choose all cash, all stock, or a split payment of C$3.75 cash plus 3.0431 Organigram shares. The combined company expects over C$50 million in synergies and targets completion by January 2027.
9 days agoAurora Cannabis trading resumes on TSX after CIRO halt
Trading in Aurora Cannabis Inc. shares resumed on the TSX at 9:50 am ET on November 3, 2026. The Canadian Investment Regulatory Organization (CIRO) lifted a temporary trading halt. The halt was implemented to ensure a fair and orderly market for all issues.
9 days agoAlberta SC dismisses Curaleaf bid to halt Aurora ATM program
Alberta Securities Commission dismissed Curaleaf's application to halt Aurora's ATM program. Aurora Cannabis can proceed with its at-the-market equity issuance strategy. The decision relates to a dispute between two major North American cannabis firms.
17 days agoAurora cannabis board rejects curaleaf hostile bid
Aurora Cannabis board unanimously recommends rejecting Curaleaf's hostile bid. Decision based on special committee's assessment of revised offer terms. Bid was updated via Notice of Variation filed on October 6, 2026. Board cites inadequate value for current shareholders as primary reason.
29 days agoAurora Cannabis doubles flower output with German facility expansion
Completed multi-million-dollar expansion of Leuna, Germany facility. Annual flower output expected to more than double. Enhanced EU-GMP capacity supports growing European market demand. Integration of proprietary genetics ensures consistent product quality.
1mo agoAurora Cannabis urges shareholders to take no action on Curaleaf bid
Aurora Cannabis Inc. advised shareholders to take no action on Curaleaf's revised bid. Curaleaf increased implied consideration to US$5.00 per Aurora share. Offer includes 0.4013 Curaleaf shares plus US$1.00 in cash per share. Aurora responded to Curaleaf's Notice of Variation and Change filing.
1mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $1,437.29 | +0.35% | $13,52,123.38M | 39.43 | |
| $280.41 | -0.13% | $6,75,033.80M | 31.06 | |
| $294.98 | +0.37% | $5,21,411.37M | 72.17 | |
| $147.18 | -0.59% | $3,62,834.91M | 117.74 | |
| $160.32 | -1.80% | $3,26,222.34M | 23.23 | |
| $185.48 | -0.69% | $2,87,691.54M | 24.32 | |
| $468.11 | +0.62% | $2,53,205.85M | 26.86 | |
| $169.73 | -0.67% | $2,10,522.74M | - | |
| $29.45 | +0.31% | $1,67,860.70M | 36.79 | |
| $41.09 | +0.96% | $1,39,300.36M | 11.15 | |
| $62.91 | +0.18% | $1,28,593.45M | 14.67 | |
| $48.43 | +0.41% | $1,16,984.89M | 23.63 |
An investment of $100 made 5 years ago in Aurora Cannabis is now worth
$ 6.60
Resulting in a loss of
$ 93.40 (93.40%)
Note: Past profits do not guarantee future returns.
